Natural product for the treatment of Alzheimer’s disease
Journal of Basic and Clinical Physiology and Pharmacology · 26.09.2017 · 28 (5) · 413-423
DOI: 10.1515/jbcpp-2016-0147 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Basic and Clinical Physiology and Pharmacology, online erschienen am 14.07.2017. Verfasst von Thanh Tung Bui und 1 weiteren Autor:innen. Beteiligte Einrichtung: . Die Arbeit wurde bisher 120-mal zitiert (Crossref) und nennt 120 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is related to increasing age. It is mainly characterized by progressive neurodegenerative disease, which damages memory and cognitive function. Natural products offer many options to reduce the progress and symptoms of many kinds of diseases, including AD. Meanwhile, natural compound structures, including lignans, flavonoids, tannins, polyphenols, triterpenes, sterols, and alkaloids, have anti-inflammatory, antioxidant, anti-amyloidogenic, and anticholinesterase activities. In this review, we summarize the pathogenesis and targets for treatment of AD. We also present several medicinal plants and isolated compounds that are used for preventing and reducing symptoms of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- .
Zitieren
APA
Bui, T. T., & Nguyen, T. H. (2017). Natural product for the treatment of Alzheimer’s disease. Journal of Basic and Clinical Physiology and Pharmacology, 28(5), 413-423. https://doi.org/10.1515/jbcpp-2016-0147
Vancouver
Bui TT, Nguyen TH. Natural product for the treatment of Alzheimer’s disease. Journal of Basic and Clinical Physiology and Pharmacology. 2017;28(5):413-423. doi:10.1515/jbcpp-2016-0147
BibTeX
@article{Bui2017,
author = {Bui, Thanh Tung and Nguyen, Thanh Hai},
title = {Natural product for the treatment of Alzheimer’s disease},
journal = {Journal of Basic and Clinical Physiology and Pharmacology},
year = {2017},
volume = {28},
number = {5},
pages = {413--423},
doi = {10.1515/jbcpp-2016-0147}
}
EUVIMED